PARLIAMENTARY WRITTEN QUESTION
Dementia: Medical Treatments (6 October 2017)
Question Asked
To ask the Secretary of State for Health, what assessment he has made of the potential effect of withdrawal from the European Medicines Agency on access to new treatments for people with dementia.
Asked by:
Kerry McCarthy (Labour)
Asked by:
Kerry McCarthy (Labour)
Answer
The Government has clearly stated the United Kingdom’s desire to work collaboratively with the European Union on the issue of medicines regulation. It is in the interest of patients for us to find a way to continue UK-EU collaboration. We want to make sure patients continue to get rapid access to new and innovative medicines and devices, including treatments for people with dementia, and that the quality, safety and efficacy of those medicines and devices are maintained.
Answered by:
Steve Brine (Conservative)
11 October 2017
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.